Avadel Pharmaceuticals
AVDL
#5789
Rank
A$1.31 B
Marketcap
$13.60
Share price
-0.23%
Change (1 day)
-50.49%
Change (1 year)

Earnings for Avadel Pharmaceuticals (AVDL)

Earnings in 2024 (TTM): -A$74.88 Million

According to Avadel Pharmaceuticals 's latest financial reports the company's current earnings are A$0.16 Billion. , an increase over its 2023 earnings that were of -A$0.25 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Avadel Pharmaceuticals from 1996 to 2024

Annual earnings

Year Earnings Change
2024 -A$76.29 Million-69.47%
2023 -A$0.25 Billion44.27%
2022 -A$0.18 Billion19.64%
2021 -A$0.15 Billion1732.84%
2020 -A$7.9 Million-86.83%
2019 -A$59.97 Million-65.92%
2018 -A$0.18 Billion-222.16%
2017 A$0.14 B-1053.49%
2016 -A$15.11 Million-112.59%
2015 A$0.11 B-185.94%
2014 -A$0.14 Billion66.04%
2013 -A$84.08 Million582.16%
2012 -A$12.33 Million-7.6%
2011 -A$13.34 Million-2.1%
2010 -A$13.63 Million32.52%
2009 -A$10.29 Million-64.36%
2008 -A$28.86 Million-52.93%
2007 -A$61.29 Million5.66%
2006 -A$58.01 Million17.86%
2005 -A$49.22 Million-375.09%
2004 A$17.88 M-406.44%
2003 -A$5.84 Million-145.2%
2002 A$12.91 M-363.36%
2001 -A$4.91 Million-80.62%
2000 -A$25.31 Million132.68%
1999 -A$10.88 Million-50.34%
1998 -A$21.91 Million54.85%
1997 -A$14.15 Million-28.35%
1996 -A$19.74 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$28.22 Million-63.01%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$16.11 Million-78.89%๐Ÿ‡บ๐Ÿ‡ธ USA